Serca Pharmaceuticals AS is a Norwegian AS based in Oslo, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2018, the company has 0 employees and reported revenue of 3,0 mill. kr in its latest annual filing.
In its most recent annual report (2025), Serca Pharmaceuticals AS reported revenue of 3,0 mill. kr, a decrease of 37% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of 131,8k kr, and the EBITDA margin stood at 0.4%.
At the end of 2025, equity financed 69.3% of the balance sheet, and current assets covered short-term debt 3.2 times.
Frequently asked questions
What is the Org number of Serca Pharmaceuticals AS?
Serca Pharmaceuticals AS is registered with Brønnøysundsregistrene under Org 921663846.
What is the revenue of Serca Pharmaceuticals AS?
Serca Pharmaceuticals AS reported revenue of 3,0 mill. kr in 2025.
Who is the CEO of Serca Pharmaceuticals AS?
Kjetil Hestdal is the CEO of Serca Pharmaceuticals AS.
Who is the chairman of Serca Pharmaceuticals AS?
Erlend Petter Skagseth chairs the board of Serca Pharmaceuticals AS, in role since 2019.
Where is Serca Pharmaceuticals AS headquartered?
Serca Pharmaceuticals AS's registered address is Gaustadalléen 21, 0349 Oslo.
